跳至主要内容
临床试验/ACTRN12608000229370
ACTRN12608000229370已完成4 期

A randomised study to investigate the effect of high and normal protein content in weight loss diets on bone density in overweight post menopausal women.

CSIRO Human Nutrition0 个研究点目标入组 200 人开始时间: 2008年5月2日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 70 Years(—)
性别
Female

入选标准

  • Female, post menopausal
  • Aged between 40-70 years
  • Body Mass Index (BMI) greater than 27, but a maximum weight of 140kg
  • Participants must understand the procedures involved and agree to participate in the study by giving full informed, written consent

排除标准

  • Body mass index (BMI) less than 27
  • Taking antiresorptive agents –including Hormone Replacement Therapy
  • Vitamin D and/or parathyroid hormone (PTH) and/or serum calcium levels outside the normal range when tested at baseline. If vitamin D is less than 60 and PTH is normal participants will continue in the study but if PTH is also elevated then the participant will be withdrawn and referred to their GP for active treatment.
  • Taking agents affecting calcium and bone metabolism such as calcium supplements, steroids or diuretics.
  • Bone density in the osteoporotic density range (total hip 2 SD below normal) or a history of low trauma peripheral or spinal fracture (with density <1 SD below normal) as assessed at the baseline examination.
  • Have a malignancy, or a history of metabolic disease such as liver, renal, unstable cardiovascular, respiratory or gastrointestinal disease.
  • Have high uncontrolled hypertension (resting recumbent Blood Pressure >160/100 mmHg). Once controlled on medication the participant can enter the study
  • History of heavy alcohol consumption (> 5 standard drinks/day)
  • Unwilling to be randomized to either trial group
  • Extended absences due to travel or other commitments
  • Unable to comprehend or cope with study requirements
  • At the commencement of the study bone density at the hip, spine and forearm will be measured. Those women in the osteoporotic density range (very low bone density ) at the first examination will not be eligible to participate but will be referred back to their general practitioner for specific treatment. Those with osteopenia (moderately low bone density) and no fractures will be able to continue in the study if they wish.

研究者

发起方
CSIRO Human Nutrition

相似试验